keyword
MENU ▼
Read by QxMD icon Read
search

Ambrisenten

keyword
https://www.readbyqxmd.com/read/26250495/pulmonary-hypertension-in-idiopathic-pulmonary-fibrosis-with-mild-to-moderate-restriction
#1
RANDOMIZED CONTROLLED TRIAL
Ganesh Raghu, Steven D Nathan, Juergen Behr, Kevin K Brown, James J Egan, Steven M Kawut, Kevin R Flaherty, Fernando J Martinez, Athol U Wells, Lixin Shao, Huafeng Zhou, Noreen Henig, Javier Szwarcberg, Hunter Gillies, Alan B Montgomery, Thomas G O'Riordan
The clinical course of pulmonary hypertension (PH) in idiopathic pulmonary fibrosis (IPF) is not known except in advanced disease.488 subjects in a placebo-controlled study of ambrisentan in IPF with mild-moderate restriction in lung volume, underwent right heart catheterisation (RHC) at baseline and 117 subjects (24%) had repeated haemodynamic measurements at 48 weeks. The subjects were categorised into a) World Health Organization (WHO) Group 3 PH (PH associated with pulmonary disease), n=68 (14%); b) WHO Group 2 PH (PH associated with left-sided cardiac disease), n=25 (5%); c) no PH but elevated pulmonary artery wedge pressure (PAWP), n=21 (4%); and d) no PH but without elevation of PAWP, n=374 (77%)...
November 2015: European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"